Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8183280 FAP inhibitors

Patent 8183280 was granted and assigned to Vantia Limited on May, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Vantia Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

81832800

Patent Inventor Names

David Michael Evans0

John Horton0

Julie Elizabeth Trim0

Date of Patent

May 22, 2012

Patent Application Number

119912860

Date Filed

August 31, 2006

Patent Citations Received

‌

US Patent 11858924 N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides

‌

US Patent 11655235 Pyrrolidine and piperidine compounds

‌

US Patent 11780821 Inhibitors of fibroblast activation protein

Patent Primary Examiner

‌

Joseph Kosack

Patent abstract

The present invention concerns compounds, according to general formula (I), which find utility preferably for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8183280 FAP inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API